Best Practices

BEST PRACTICES: An Oral Treatment for Moderate to Severe Plaque Psoriasis


 

A Best Practices Supplement to Dermatology News. This supplement was sponsored by Celgene Corporation.

Faculty/Faculty Disclosures

Alan Menter, MD
Baylor University Medical Center
Dallas, TX

Dr Menter is on the advisory board for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli Lilly, Genentech Inc., Janssen Biotech, Inc., LEO Pharma and Pfizer; is a consultant for AbbVie, Allergan, Amgen, Convoy Therapeutics, Inc., Eli Lilly, Janssen Biotech, Inc., LEO Pharma, Novartis, Pfizer, Syntrix, Vitae, Wyeth and XenoPort; is an investigator for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen Biotech, Inc., LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho, Syntrix and Wyeth; is a speaker for AbbVie, Amgen, Janssen Biotech, Inc., LEO Pharma and Wyeth; has received grant funds from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene, Genentech, Janssen Biotech, Inc., LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho and Syntrix; and has received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Convoy Therapeutics, Inc., Eli Lilly, Genentech, Janssen Biotech, Inc., LEO Pharma, Novartis, Pfizer, Syntrix, Vitae, Wyeth and XenoPort.

Copyright © by Frontline Medical Communications Inc.

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge